Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO WCGIC 2022 | Highlights in biliary tract and liver cancers from ESMO WCGIC 2022

Aiwu Ruth He • 5 Jul 2022
ESMO WCGIC 2022
Bile Duct Cancer Liver Cancer

Aiwu Ruth He, MD, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA highlights several key updates in the fields of biliary tract and liver cancers from ESMO WCGIC 2022. Dr He comments on notable updates in immunotherapy and personalized therapy strategies, specifically for hepatocellular carcinoma (HCC). This interview took place at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer (ESMO WCGIC) 2022 in Barcelona, Spain.

More from Aiwu Ruth He

Future developments in immunotherapy for treatment of biliary tract cancer
2:05
Future developments in immunotherapy for treatment of biliary tract cancer
Aiwu Ruth He • 5 Jul 2022
Subgroup analysis of the TOPAZ-1 study by primary tumor location
5:45
Subgroup analysis of the TOPAZ-1 study by primary tumor location
Aiwu Ruth He • 5 Jul 2022

Related Videos

Targeting GPC3 in HCC: bsAbs, ADCs and CAR-T
1:43
Targeting GPC3 in HCC: bsAbs, ADCs and CAR-T
Hong Jae Chon • 26 Oct 2026
BGB-B2033: a novel GPC3/4-1BB-targeting bispecific antibody in liver cancer
1:56
BGB-B2033: a novel GPC3/4-1BB-targeting bispecific antibody in liver cancer
Hong Jae Chon • 26 Oct 2026
GI highlights at ESMO 2026: Companion-002, EMERALD-3 and HARMONi-GI1
1:22
GI highlights at ESMO 2026: Companion-002, EMERALD-3 and HARMONi-GI1
Hong Jae Chon • 26 Oct 2026
Phase Ib/IIa trial of fostrox and lenvatinib in advanced HCC
2:34
Phase Ib/IIa trial of fostrox and lenvatinib in advanced HCC
Hong Jae Chon • 26 Oct 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals